Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Children with alopecia areata have more exclamation mark hairs and fewer yellow dots than adults.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Children with alopecia areata often have low vitamin D, especially if they have darker skin, it's not summer, or they're not White.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Skin color may change how alopecia areata looks under a dermoscope.

Activating Tgr5 may help treat hair loss and bone loss.

Alopecia areata greatly affects the quality of life for children and their families.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.